ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,020
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Diabetes - Perspectives in Drug Therapy
other
Editor(s):
Mathias Schwanstecher
Publication date
(Print):
2011
Publisher:
Springer Berlin Heidelberg
Read this book at
Publisher
Further versions
oa repository (via OAI-PMH doi match)
Powered by
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Creative Arts in Education and Therapy (CAET) – Eastern and Western Perspectives
Author and book information
Book
ISBN (Print):
978-3-642-17213-7
ISBN (Electronic):
978-3-642-17214-4
Publication date (Print):
2011
DOI:
10.1007/978-3-642-17214-4
SO-VID:
4aa4353b-52f1-4a51-9d96-3476e6ada5fc
License:
http://www.springer.com/tdm
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. E1
Erratum to Chapter 11: Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes
pp. 1
Targeting Type 2 Diabetes
pp. 35
Dual Acting and Pan-PPAR Activators as Potential Anti-diabetic Therapies
pp. 53
GLP-1 Agonists and Dipeptidyl-Peptidase IV Inhibitors
pp. 75
Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
pp. 105
SGLT Inhibitors as New Therapeutic Tools in the Treatment of Diabetes
pp. 127
Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 in Antidiabetic Therapy
pp. 147
Nampt and Its Potential Role in Inflammation and Type 2 Diabetes
pp. 165
Inhibition of Ganglioside Biosynthesis as a Novel Therapeutic Approach in Insulin Resistance
pp. 179
Overcoming Insulin Resistance with Ciliary Neurotrophic Factor
pp. 201
Thermogenesis and Related Metabolic Targets in Anti-Diabetic Therapy
pp. 257
Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes
pp. 279
Fructose-1, 6-Bisphosphatase Inhibitors for Reducing Excessive Endogenous Glucose Production in Type 2 Diabetes
pp. 303
AMP-Activated Protein Kinase and Metabolic Control
pp. 331
Mitochondria as Potential Targets in Antidiabetic Therapy
pp. 357
Research and Development of Glucokinase Activators for Diabetes Therapy: Theoretical and Practical Aspects
Similar content
1,020
Repurposing of drugs against methyltransferase as potential Zika virus therapies
Authors:
Rohit Shukla
,
Anshuman Chandra
,
Anuj Kumar
…
Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting.
Authors:
Stephen Davis
,
Wenhui Wei
,
Satish Garg
NDIS and occupational therapy: compatible in intention and purpose from the consumer perspective.
Authors:
Mark Russi
See all similar